| Application no. and date | 13167148.9 (espacenet) (Federated) (European Patent Register), 20130508 | | Patent/reg. no. and date | DK/EP 2662094, 20240417 | | Publication date | 20131113 | | Priority no. and date | US 201261644122 P, 20120508, US 201361777475 P, 20130312 | | EP pub. no. and date |
EP 2662094 20131113 | | Effective date | | | Applicant/owner | Onyx Therapeutics, Inc., One Amgen Center Drive
Thousand Oaks, CA 91320-1799, US | | Applicant ref. no. | 1707504 | | Inventor | Lewis, Evan, 631 Miller Ave
Pacifica, CA California 64044, US,
Shwonek, Peter, 436 Capistrano Ave
San Francisco, CA California 94112, US,
Dalziel, Sean, 400 Beale Street, Apt. 1901
San Francisco, CA California 94105, US,
Jumaa, Mouhannad, 363 Catamaran St
Foster City, CA California 94404, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 38/07 (2006.01) , A61K 47/69 (2017.01) , A61P 35/00 (2006.01) , B82Y 5/00 (2011.01) | | Title | Fremgangsmåder til cylodextrinkompleksdannelse til formulering af peptidproteasomhæmmere | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
